Evidence map›Paper›PMID 39697536›Full record

ArticleFrontiers in pharmacology2024

Signal detection and analysis of adverse events associated with Genvoya

Chengliang Wang, Yan Zhang, Xiting Tang, Guoping Zhang, Li Chen

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chengliang WangPeople's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, Sichuan, China.
Yan ZhangPeople's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, Sichuan, China.
Xiting TangPeople's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, Sichuan, China.
Guoping ZhangPeople's Hospital of Ganzi Tibetan Autonomous Prefecture, Kangding, Sichuan, China.
Li ChenDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to evaluate and understand the safety profile of Genvoya Methods: Data were obtained from the FAERS database, covering the period from the first quarter of 2015 to the fourth quarter of 2023, focusing on reports where Genvoya Results: A total of 2, 376 adverse drug event reports related to Genvoya Conclusion: Multiple adverse reactions were observed with the use of Genvoya

Indexed as

adverse eventsFAERS databaseGenvoya®HIV treatmentsignal mining

Identifiers

PMID39697536
PMCPMC11652195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.